Navigation Links
Leukemia Can Be Cured By Garden Plant's Root

A new pathway with regard to the progression of chronic myelogenous leukemia (CML) has reportedly been identified by US based scientists. They have also found out that an extract from the plant coleus forskohlii's root,// which is called forskolin can be used for suppressing the process. As many as 4,600 people in the US alone are expected to develop CML this year, and the findings may contribute towards their treatment options.

Many of the patients suffering from this condition have already developed a resistance to the Gleevec drug which is commonly used. The ability of the cancer cells to grow is reduced by 90% by forskolin, according to the research. Normal cell functioning can also be reinstated by forskolin, according to the study. CML results in the creation of Bcr-Abl which is a cancer-causing enzyme.

People who suffer from the early stages of the disease are usually not aware that they are suffering from the condition, when the drug Gleevec can be effectively put to use. Even though doctors were aware of the symptoms of CML, they were not aware as to what actually caused the disease to progress.

Extensive genetic and chemical tests have revealed that a protein called SET is stimulated by Bcr-Abl, which serves to inhibit the phosphatase PP2A, thus permitting cancer cells to grow freely. The PP2A function can be restored by forskolin, according to the research, while it will not adversely affect normal cells.
'"/>




Page: 1

Related medicine news :

1. Cyclosporin A Treats Leukemia Complications
2. Leukemia pill shows promise against stomach cancer
3. Aspirin Lowers Leukemia Risk
4. Hope for Chemo-Resistant Leukemia Patients
5. Genes Found To Help Leukemia Treatment
6. Looking Towards More Effective Leukemia Treatment
7. Diet Found To Offer Protection Against Leukemia
8. Exposure To Night Light may Increase The Risk Of Leukemia
9. Skin Allergies Found To Increase The Risk Of Leukemia
10. Understanding Gene Profiles Could Help Cure A Resistant Form Of Leukemia In Kids
11. Night Light Found To Increase The Risk Of Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... ... 2017 , ... Tribble Insurance Agency, a family owned and operated firm offering ... charity event to honor Chad Phillip Dermyer, a local police trooper who was shot ... and his fellow officers were conducting routine stops of suspects when one of them, ...
(Date:1/19/2017)... ... January 19, 2017 , ... For the second consecutive year, ... Connecticut (RMACT) have earned “Top Doctor” awards. Dr. Mark Leondires, Dr. Spencer Richlin, ... been chosen by their peers for the 2017 list based on their exceptional ...
(Date:1/19/2017)... ... January 19, 2017 , ... Sales Focus Inc. (SFI), a Maryland-based sales ... market. , Over the past 20 years SFI has been recognized as the world’s ... six new clients into the US market. The new clients include: Panacea Pro, ...
(Date:1/19/2017)... ... January 19, 2017 , ... Fillers are known ... Few people know that popular cosmetic fillers can enhance earlobes and ... medical director of the MilfordMD Cosmetic Dermatology Surgery & Laser Center, in Milford, ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... of Bioengineering are collaborating on a research project focused on multiple sclerosis (MS). ... seeks to use nanotechnology to control the disease without compromising normal immune function ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , January 19, 2017 ... administration appears serious about reducing the FDA,s regulatory ... innovation in the medical drug industry, many of ... with new clinical trials and development of advanced ... forging ahead with recent developments include:  Moleculin Biotech, ...
(Date:1/19/2017)... 2017  Magnetic Insight Inc., leader in magnetic ... agreement with inviCRO LLC to develop intuitive image ... based on inviCRO,s VivoQuant™ visualization and post processing ... complete MPI solution package with the Momentum MPI ... imaging in vivo. MPI is a ...
(Date:1/18/2017)... 18, 2017  EnteroMedics Inc. (NASDAQ: ... neuroblocking technology to treat obesity, metabolic diseases and ... an underwritten public offering of units for gross ... discounts and commissions and offering expenses payable by ... Class A Units, priced at a public offering ...
Breaking Medicine Technology: